An Enduring CME Activity – 1.0 CEUs
DISEASE MODIFYING APPROACHES FOR TYPE 1 DIABETES
LEARN ABOUT THE THREE STAGES OF DEVELOPING TYPE 1 DIABETES AND POSSIBLE INTERVENTIONS TO DELAY OR PREVENT THE DEVELOPMENT OF T1D
A new diagnosis of type 1 diabetes typically is a traumatic event for the patient and the entire family, as it was for Drs. Steve Edelman and Jeremy Pettus when they were both diagnosed with T1D at age 15. A new T1D individual usually ends up in DKA in the ICU and leaves the hospital measuring their glucose values multiple times a day, self-injecting insulin, starting a new restricted diet, and many more life-changing events. The first disease-modifying therapy (teplizumab or TZIELD) was recently approved for individuals who have tested positive for islet autoantibodies. This program will review the etiology type 1 diabetes, including the three stages, how to screen individuals at risk, and the mechanism of teplizumab and how to administer it.
Successful Completion
To receive a Statement of Credit you must view the entire 60 min enduring activity. At the conclusion of the video there will be a link to complete/pass the post-test and submit a program evaluation. Your Statement of Credit will be issued electronically immediately upon submission of the evaluation in a downloadable format. You are responsible for downloading and saving your certificate. Contact Sarah Severance at sarah@tcoyd.org with questions.
Program Fees and Registration
This is a complimentary program. Registration is not required to view the materials, however to obtain credit learners will be required to submit necessary identifying information, complete a post-test, and evaluation.
Acknowledgement of Joint Providership
This activity is jointly provided by The Association of Diabetes Care & Education Specialists (ADCES) and TCOYD. The Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. ADCES’ Joint Accreditation Status also includes the Commission on Dietetic Registration (CDR) and American Academy of Physician Assistants (AAPA). ADCES will provide accreditation for this activity to ensure the content is scientifically based, accurate, current, and objective. Any conflicts among faculty or others involved in the planning and execution of this activity will be resolved.
This activity is provided as enduring material via www.tcoyd.org and will be available from 6/29/23 to 6/29/24.
SPEAKERS & FACULTY
*extra-relatable faculty (they're living with type 1)
*STEVEN V. EDELMAN, MD
Founder & Director, TCOYD; Endocrinologist, Clinical Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego
Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report.
*JEREMY PETTUS, MD
Type 1 Track & Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him at TCOYD.
PROGRAM TOPICS
1. Defining the “Problem”
2. The Etiology and Pathology of T1D
3. The 3 stages of Type 1 Diabetes and How They are Defined
4. The Autoantibodies Associated with T1D and the Associated Risk of Developing T1D Over Time
5. Stage 2 Interventions (prevention)
6. Stage 3 Interventions (preservation)
7. Long Standing T1D Interventions (cellular replacement)
LEARNING OBJECTIVES
Upon completion of these activities, participants should:
1. Understand the etiology of type 1 diabetes and be able to describe the 3 stages of T1D
2. Be able to describe the best ways to diagnose T1D in the earlier stages and what auto-antibodies are used to screen individuals at risk for developing T1D
3. Be able to discuss with an individual with 2 or more islet auto-antibodies the benefits and adverse events associated with being treated with teplizumab
WHO CAN BENEFIT MOST
This course is designed for diabetes healthcare providers including endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, certified diabetes educators, pharmacists, and other healthcare providers wanting to expand their knowledge of the stages of T1D and available interventions and treatments at each stage.
– Acknowledgement of Financial Support –
This activity is supported by an educational grant from Provention Bio, Inc.
In support of improving patient care, this activity has been planned by Taking Control Of Your Diabetes® and the Association of Diabetes Care & Education Specialists. The Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Accreditation Council for Pharmacy Education
The Universal Activity Numbers are JA4008258-9999-23-277-H01-P; JA4008258-9999-23-277-H01-T. This knowledge-based activity has been approved for 1.0 contact hour(s)
American Medical Association (AMA)
Association of Diabetes Care & Education Specialists designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.0 ANCC contact hours. This activity discusses .5 contact hours of pharmacotherapeutic content.
The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.0 contact hours. 
The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This enduring activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Commission on Dietetic Registration (CDR): CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.
Certified Diabetes Care and Education Specialists: To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.
Other Health Professionals
It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.
Speaker Disclosures
Steven V. Edelman, MD
Speakers Bureau/Consultant: Lilly USA, LLC, MannKind Corporation, Sanofi-Aventis US, Inc; Board of Directors: Sensionics, Team Type 1
Jeremy H. Pettus, MD
Consultant: Carmot, Diasome, Sanofi, Novo Nordisk; Speakers Bureau: Sanofi, MannKind
Planners
Sarah Severance – No financial relationships to report
Autumn Zarlengo – No financial relationships to report